3B's Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark - Zona Industrial da Gandra, 4805-017, Barco, Guimarães, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
J Tissue Eng Regen Med. 2018 Mar;12(3):762-774. doi: 10.1002/term.2495. Epub 2017 Oct 4.
Cell-based therapies are of particular interest for tendon and ligament regeneration given the low regenerative potential of these tissues. Adipose tissue is an abundant source of stem cells, which may be employed for the healing of tendon lesions. However, human adult multipotent adipose-derived stem cells (hASCs) isolated from the stromal vascular fraction of adipose tissue originate highly heterogeneous cell populations that hinder their use in specific tissue-oriented applications. In this study, distinct subpopulations of hASCs were immunomagnetic separated and their tenogenic differentiation capacity evaluated in the presence of several growth factors (GFs), namely endothelial GF, basic-fibroblast GF, transforming GF-β1 and platelet-derived GF-BB, which are well-known regulators of tendon development, growth and healing. Among the screened hASCs subpopulations, tenomodulin-positive cells were shown to be more promising for tenogenic applications and therefore this subpopulation was further studied, assessing tendon-related markers (scleraxis, tenomodulin, tenascin C and decorin) both at gene and protein level. Additionally, the ability for depositing collagen type I and III forming extracellular matrix structures were weekly assessed up to 28 days. The results obtained indicated that tenomodulin-positive cells exhibit phenotypical features of tendon progenitor cells and can be biochemically induced towards tenogenic lineage, demonstrating that this subset of hASCs can provide a reliable source of progenitor cells for therapies targeting tendon regeneration.
鉴于这些组织的再生潜力较低,基于细胞的疗法对于肌腱和韧带再生特别有吸引力。脂肪组织是干细胞的丰富来源,可用于治疗肌腱损伤。然而,从脂肪组织基质血管部分分离的人多能脂肪来源干细胞(hASCs)起源于高度异质的细胞群体,这阻碍了它们在特定组织定向应用中的使用。在这项研究中,使用几种生长因子(GFs),即内皮 GF、碱性成纤维细胞 GF、转化 GF-β1 和血小板衍生 GF-BB,对 hASC 的不同亚群进行免疫磁分离,并评估其肌腱分化能力,这些 GFs 是众所周知的肌腱发育、生长和愈合的调节剂。在筛选的 hASC 亚群中,腱调蛋白阳性细胞在肌腱生成应用中更有前途,因此进一步研究了该亚群,评估了与肌腱相关的标志物(肌腱蛋白聚糖、腱调蛋白、腱蛋白 C 和饰胶蛋白)在基因和蛋白水平上的表达。此外,还每周评估了沉积胶原蛋白 I 和 III 形成细胞外基质结构的能力,直到 28 天。结果表明,腱调蛋白阳性细胞表现出肌腱祖细胞的表型特征,并可在生化上诱导向肌腱谱系分化,表明该亚群的 hASC 可为靶向肌腱再生的治疗提供可靠的祖细胞来源。